NCT07810283

Brief Summary

This study aims to use Electrical Impedance Tomography (EIT) to optimise breathing machines for people with problems with their breathing. This might improve their ability to use their breathing machine. By providing real-time pictures of the lungs, EIT can help clinicians tailor breathing machine settings to meet each persons needs. Long term respiratory failure is a serious condition that causes extreme difficulty breathing. There are a lot of people in the UK with respiratory failure. It costs the NHS a lot of money to support these people. People with long term respiratory failure often spend a lot of time in hospital. Non-invasive ventilation (NIV) is a key treatment for these patients. NIV is a breathing machine that supports breathing and helps get rid of waste gases (including carbon dioxide) from the lungs. Cough assist helps people to cough and clear secretion. Lots of patients find using breathing machine hard. It can be difficult to set the machines up to suit each persons needs. Electrical Impedance Tomography (EIT) is a promising technology that provides real-time pictures of the lungs without radiation exposure. A chest belt sends painless, harmless low-level electrical currents through the lungs. This creates an instant picture of the lungs. EIT has shown to be useful in critical care settings to optimise breathing machine settings. EIT in respiratory failure has not been tested. Project Goal: Assess if Electrical Impedance Tomography (EIT) can make breathing machine settings better for people with respiratory failure. Objectives: Work package 1

  • Use EIT to look at and adjust settings on breathing machines (NIV).
  • Check if adjustments using EIT help patients use their breathing machines more often.
  • Ask people if they feel any better with the machine on the new settings
  • Ask people about changes in their symptoms after the changes on the machines have been made Work package 2
  • Use EIT to observe lung air movement during mechanical insufflation-exsufflation (MI:E). Project Structure Recruitment: We aim to have 20 participants from the Royal Free Hospital. We aim to have 5-10 participants in each part of the study. Baseline Measurements: Work package 1 Body metrics, current NIV therapy, transcutaneous CO2 (TcCO2), spirometry, and forced oscillation technique (FOT), capillary blood gas(CBG). Work package 2 Spirometry, sniff nasal inspiratory pressure (SNIP), and peak cough flow, capillary blood gas. Interventions: Work package 1 Use EIT to improve settings on the breathing machine. Patients will wear the EIT belt to get a baseline. Expert clinicians will change breathing machine settings whilst looking at the EIT pictures. New and improved settings will be tested for 2-4 hours. Patients will then be sent home on these new settings and tests will be redone after one month on the new and improved settings. Work package 2 Use EIT to monitor the effects of MI:E. Participants will undergo five short MI:E sessions of 1-2minutes with a 20minute rest between sessions, with EIT attached, adjusting pressures by 20%. EIT will track the changes in how air moves within the lungs during different MI:E prescriptions. Data Analysis: We will compare the tests as baseline and one month follow-up using statistics. The statistical tests will help us work out if using EIT to guide the NIV and M I:E machine settings makes them better for patients.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
24mo left

Started Aug 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
Aug 2026Sep 2028

Study Start

First participant enrolled

August 27, 2026

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

September 2, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 9, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

September 9, 2026

Status Verified

September 1, 2026

Enrollment Period

1 year

First QC Date

September 2, 2026

Last Update Submit

September 2, 2026

Conditions

Keywords

observationalEIT

Outcome Measures

Primary Outcomes (1)

  • Concordance with NIV

    Concordance with NIV

    1month

Study Arms (2)

NIV

Use EIT to improve settings on the breathing machine. Patients will wear the EIT belt to get a baseline. Expert clinicians will change breathing machine settings whilst looking at the EIT pictures. New and improved settings will be tested for 2-4 hours. Patients will then be sent home on these new settings and tests will be redone after one month on the new and improved settings.

Device: electrical impedance tomography

MI:E

Use EIT to monitor the effects of MI:E. Participants will undergo five short MI:E sessions of 1-2minutes with a 20minute rest between sessions, with EIT attached, adjusting pressures by 20%. EIT will track the changes in how air moves within the lungs during different MI:E prescriptions.

Device: electrical impedance tomography

Interventions

Electrical Impedance Tomography (EIT) is a promising technology that provides real-time pictures of the lungs without radiation exposure. A chest belt sends painless, harmless low-level electrical currents through the lungs. This creates an instant picture of the lungs.

MI:ENIV

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Work package 1: * Patients diagnosed with chronic respiratory failure * Requiring domiciliary NIV and non-concordant with NIV (\<4hrs/night for 70% in the last 1month) * Age ≥18years Work package 2: * Age ≥18years * Patients diagnosed with a neuromuscular disease * Currently use or have previously used MI:E for clinical use or as part of a research study

You may qualify if:

  • Work package 1:
  • Patients diagnosed with chronic respiratory failure
  • Requiring domiciliary NIV and non-concordant with NIV (\<4hrs/night for 70% in the last 1month)
  • Age ≥18years
  • Work package 2:
  • Age ≥18years
  • Patients diagnosed with a neuromuscular disease
  • Currently use or have previously used MI:E for clinical use or as part of a research study

You may not qualify if:

  • Unable to provide informed consent
  • Contraindication to EIT:
  • Active implantable cardiac device
  • Active pacemaker
  • Open wound over the site of the EIT belt
  • Chest circumference \< 80cm or \> 116cm
  • Psychosocial factors attributable to non-concordance
  • Excessive mask leak contributing to non-concordance
  • Mental health diagnosis contributing to non-concordance
  • Pregnancy
  • Unable to provide informed consent
  • Contraindication to EIT:
  • Active implantable cardiac device
  • Active pacemaker
  • Open wound over the site of the EIT belt
  • +14 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Free Hospital

London, United Kingdom

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveObesity

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 2, 2026

First Posted

September 9, 2026

Study Start

August 27, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2028

Last Updated

September 9, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations